Skip to main content

Diagnostic and Prognostic Significance of Tumor Angiogenesis

  • Chapter
The New Angiotherapy

Abstract

The significance of tumor angiogenesis has been recognized for many centuries. Fallopio in the 1600s stated “cancers have dilated swollen veins resembling the legs of a crab, and this I single out from many signs since if its cure is undertaken the man nevertheless dies of the same cancer.” However, it has only been since the turn of the century that continual and widespread research has been been performed, and it was not until the 1970s when Folkman and colleagues aroused interest in pathological angiogenesis that the first attempt was made to generate a systematic method for quantifying angiogenesis. The score was based on the assessment of several morphological parameters of “endothelial cell regeneration” stained by routine histological methods. Named the MAGS score (Microscopic Angiogenesis Grading System), it assessed the number of vessels, the degree of endothelial-cell hyperplasia, and the cytology of the tumor endothelium (1). The aim was to develop an objective method for quantifying the tumor neovasculature that could be used as a standard for angiogenesis reasearch, to compare with other clinicopathological characteristics and be useful in the development and assessment of efficacy of anti-angiogenic agents and vascular targeting therapies (2). However, many of the difficulties that still impede the clinical utility of angiogenesis quantitation systems today, including problems of tissue-sample selection, inter- and intraobserver variation, were such that the technique was not adopted. Further attempts to assess tumor angiogenesis were carried out using a variety of nonspecific endothelial markers but it has been only in the last five years, with the advent of highly specific endothelial markers (3–5) that can be used in histological archival tissues, that quantitation studies have been performed. As indicated earlier, there are still limitations to the current methodologies for measuring tumor angiogenesis but new methods are continually being assessed (see below). Furthermore, many of these mght have potential supplementary clinical uses such as in diagnosis, prediction of treatment response, and monitoring of disease status. Such methods might also be applied to other common and debilitating diseases such as psoriasis, rheumatoid arthritis (RA), atherosclerosis, and diabetic retinopathy where angiogenesis is central to the pathological process.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brem, S., Cotran, R., and Folkman, J. (1972) Tumor angiogenesis: a quantitative method for histological grading. J. Natl. Cancer Inst. 48, 34–356.

    Google Scholar 

  2. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 82–86.

    Article  Google Scholar 

  3. Mlynek, M., van Beunigen, D., Leder, L.-D., and Streffer, C. (1985) Measurement of the grade of vascularisation in histological tumor tissue sections. Br. J. Cancer 52, 945–948.

    Article  PubMed  CAS  Google Scholar 

  4. Svrivastava, A., Laidler, P., Davies, R., Horgan, K., and Hughes, L. (1988) The prognostic significance of tumor vascularity in intermediate thickness (0.76–4.0mm thick) skin melanoma. Am. J. Pathol. 133, 419–423.

    Google Scholar 

  5. Porschen, R., Classen, S., Piontek, M., and Borchard, F. (1994) Vascularization of carcinomas of the esophagus and its correlation with tumor proliferation. Cancer Res. 54, 587–91.

    PubMed  CAS  Google Scholar 

  6. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1–8.

    Article  PubMed  CAS  Google Scholar 

  7. Page, D. L. and Dupont, W. D. (1992) Breast cancer angio-histogenesis: through a narrow window [editorial; comment]. J. Natl. Cancer Inst. 84, 1850–1851.

    Article  PubMed  CAS  Google Scholar 

  8. Page, D. and Jensen, R. (1995) Angiogenesis in human breast carcinoma. Human Pathol. 26, 1173–1174.

    Article  CAS  Google Scholar 

  9. Protopapa, E., Delides, G. S., and Revesz, L. (1993) Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy. Eur. J. Cancer. 29A, 1141–1145.

    Article  Google Scholar 

  10. Wakui, S., Furusato, M., Itoh, T., Sasaki, H., Akiyama, A., Kinoshita, I., (1992) Tumor angiogenesis in prostatic carcinoma with and without bone marrow metastases: a morphometric study. J. Pathol. 168, 257–262.

    Article  PubMed  CAS  Google Scholar 

  11. Carnochan, P., Briggs, J. C., Westbury, G., and Davies, A. J. (1991) The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85–1.25 mm in thickness. Br. J. Cancer 64, 102–107.

    Article  PubMed  CAS  Google Scholar 

  12. Barnhill, R. L., Fandrey, K., Levy, M. A., Mihm, M. J., and Hyman, B. (1992) Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab. Invest. 67, 331–337.

    PubMed  CAS  Google Scholar 

  13. Visscher, D., Smilanetz, S., Drozdowicz, S., and Wykes, S. (1993) Prognostic significance of image morphometric microvessel enumeration in breast carcinoma. Anal. Quant. Cytol. 15, 88–92.

    CAS  Google Scholar 

  14. Visscher, D., DeMattia, F., and Boman, S. (1994) Technical factors affecting image morphometric microvessel density counts in breast carcinomas. Lab. Invest. 70, 168A (abstract).

    Google Scholar 

  15. Vesalainen, S., Lipponen, P., Talja, M., Alhava, E., and Syrjanen, K. (1994) Tumor vascularity and basement membrane structure as prognostic factors in T1–2M0 prostatic adenocarcinoma. Anticancer Res. 14, 709–714.

    PubMed  CAS  Google Scholar 

  16. Kuzu, I., Bicknell, R., Harris, A. L., Jones, M., Gatter, K. C., and Mason, D. Y. (1992) Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumors. J. Clin. Pathol. 45, 143–148.

    Article  PubMed  CAS  Google Scholar 

  17. Schlingemann, R. O., Rietveld, F. J., Kwaspen, F., van, d. K. P., de, W. R., and Ruiter, D. J. (1991) Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138, 1335–1347.

    PubMed  CAS  Google Scholar 

  18. Page, C., Rose, M., Yacoub, M., and Pigott, R. (1992) Antigenic heterogeneity of vascular endothelium. Am. J. Pathol. 141, 673–683.

    PubMed  CAS  Google Scholar 

  19. Horak, E. R., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N.,(1992) Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340, 1120–1124.

    Article  PubMed  CAS  Google Scholar 

  20. Parums, D., Cordell, J., Micklem, K., Heryet, A., Gatter, K., and Mason, D. (1990) JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J. Clin. Pathol. 43, 752–757.

    Article  PubMed  CAS  Google Scholar 

  21. Dickinson, A. J., Fox, S. B., Persad, R. A., Hollyer, J., Sibley, G. N., and Harris, A. L. (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br. J. Urol. 74, 762–766.

    Article  PubMed  CAS  Google Scholar 

  22. Fox, S., Leek, R., Smith, K., Hollyer, J., Greenall, M., and Harris, A. (1994) Tumor angiogenesis in node negative breast carcinomas-relationship to epidermal growth factor receptor and survival. Breast Cancer Res. Treat. 29, 109–116.

    Article  PubMed  CAS  Google Scholar 

  23. Toi, M., Kashitani, J., and Tominaga, T. (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer. 55, 371–374.

    Article  PubMed  CAS  Google Scholar 

  24. Siitonen, S., Haapasalo, H., Rantala, I., Helin, H., and Isola, J. (1995) Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Mod. Pathol. 8, 745–752.

    PubMed  CAS  Google Scholar 

  25. Tanigawa, N., Matsumura, M., Amaya, H., Kitaoka, A., Shimomatsuya, T., Lu, C., (1997) Tumor vascularity correlates with the prognosis of patients with esophageal squamous carcinoma. Cancer 79, 220–225.

    Article  PubMed  CAS  Google Scholar 

  26. Weidner, N., Folkman, J., Pozza, F., Bevilacqua, P., Allred, E. N., Moore, D. H., (1992) Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875–1887.

    Article  PubMed  CAS  Google Scholar 

  27. Weidner, N., Gasparini, G., Bevilacqua, P., Maluta, S., Palma, P., Caffo, O., (1994) Tumor microvessel density, p53 expression, and tumor size are relevant prognostic markers in node negative breast carcinomas. Lab. Invest. 70, A24 (abstract).

    Google Scholar 

  28. Burrows, F. J. and Thorpe, P. E. (1994) Vascular targeting: a new approach to the therapy of solid tumors. Pharmacol. Ther. 64, 155–174.

    Article  PubMed  CAS  Google Scholar 

  29. Wang, J. M., Kumar, S., Pye, D., Haboubi, N., and Al-Nakib, L. (1994) Breast carcinoma: comparative study of tumor vasculature using two endothelial cell markers. J. Natl. Cancer Inst. 86, 386–388.

    Article  PubMed  CAS  Google Scholar 

  30. Kaczmarek, J., Castellani, P., Nicolo, G., Spina, B., Allemanni, G., and Zardi, L. (1994) Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer 58, 11–16.

    Article  Google Scholar 

  31. Fox, S., Gatter, K., Bicknell, R., Going, J., Stanton, P., Cooke, T., and Harris, A. (1993) Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res. 53, 9161–9163.

    Google Scholar 

  32. Fox, S., Turner, G., Gatter, K., and Harris, A. (1995) The increased expression of adhesion molecules ICAM-3, E and P selectin on breast cancer endothelium. J. Pathol. 177, 369–376.

    CAS  Google Scholar 

  33. Van Hoef, M. E., Knox, W. F., Dhesi, S. S., Howell, A., and Schor, A. M. (1993) Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer 29A, 1141–1145.

    Article  Google Scholar 

  34. Hall, N. R., Fish, D. E., Hunt, N., Goldin, R. D., Guillou, P. J., and Monson, J. R. (1992) Is the relationship between angiogenesis and metastasis in breast cancer real? Surg. Oncol. 1, 223–229.

    Article  PubMed  CAS  Google Scholar 

  35. Sahin, A., Sneige, N., Singletary, E., and Ayala, A. (1992) Tumor angiogenesis detected by Factor-VIII immunostaining in node-negative breast carcinoma (NNBC): a possible predictor of distant metastasis. Mod. Pathol. 5, 17A (abstract).

    Google Scholar 

  36. Sightler, H., Borowsky, A., Dupont, W., Page, D., and Jensen, R. (1994) Evaluation of tumor angiogenesis as a prognostic marker in breast cancer. Lab. Invest. 70, 22A (abstract).

    Google Scholar 

  37. Fox, S. B., Leek, R. D., Weekes. M P, Whitehouse, R. M., Gatter, K. C., and Harris, A. L. (1995) Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J. Pathol. 177, 275–283.

    Article  PubMed  CAS  Google Scholar 

  38. Axelsson, K., Ljung, B., Moore II, D., Thor, A., Chew, K., Edgerton, S., (1995) Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma. J. Natl. Cancer Inst. 87.

    Google Scholar 

  39. Barbareschi, M., Weidner, N., Gasparini, G., Morelli, L., Forti, S., Eccher, C., (1995) Microvessel quantitation in breast carcinomas. Appl. Immunochem. 3, 75–84.

    Google Scholar 

  40. Simpson, J., Ahn, C., Battifora, H., and Esteban, J. (1994) Vascular surface area as a prognostic indicator in invsasive breast carcinoma. Lab. Invest. 70, 22A.

    Google Scholar 

  41. Brawer, M. K., Deering, R. E., Brown, M., Preston, S. D., and Bigler, S. A. (1994) Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer 73, 678–687.

    Article  PubMed  CAS  Google Scholar 

  42. Furusato, M., Wakui, S., Sasaki, H., Ito, K., and Ushigome, S. (1994) Tumor angiogenesis in latent prostatic carcinoma. Br. J. Cancer 70, 1244–1246.

    Article  PubMed  CAS  Google Scholar 

  43. Bigler, S., Deering, R., and Brawer, M. (1993) Comparisons of microscopic vascularity in benign and malignant prostate tissue. Human Pathol. 24, 220–226.

    Article  CAS  Google Scholar 

  44. Williams, J K, Carlson, G. W., Cohen, C., Derose, P. B., Hunter, S., and Jurkiewicz, M. J. (1994) Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am. J. Surg. 168, 373–380.

    Article  PubMed  CAS  Google Scholar 

  45. Wesseling, P., Vandersteenhoven, J. J., Downey, B. T., Ruiter, D. J., and Burger, P. C. (1993) Cellular components of microvascular proliferation in human glial and metastatic brain neoplasms. A light microscopic and immunohistochemical study of formalin-fixed, routinely processed material. Acta. Neuropathol. (Berl.) 85, 508–514.

    Article  CAS  Google Scholar 

  46. Charpin, C., Devictor, B., Bergeret, D., Andrac, L., Boulat, J., Horschowski, N., (1995) CD31 Quantitative immunocytochemical assays in breast carcinomas. Am. J. Clin. Pathol. 103, 443–448.

    PubMed  CAS  Google Scholar 

  47. Fox, S., Turner, G., Leek, R., Whitehouse, R., Gatter, K., and Harris, A. (1995) The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Br. Cancer Res. Treat. 36, 219–226.

    Article  CAS  Google Scholar 

  48. Chalkley, H. (1943) Method for the quantative morphological analysis of tissues. J. Natl. Cancer Inst. 4, 47–53.

    Google Scholar 

  49. Bosari, S., Lee, A. K., DeLellis, R. A., Wiley, B. D., Heatley, G. J., and Silverman, M. L. (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol. 23, 755–761.

    Article  PubMed  CAS  Google Scholar 

  50. Guinebretiere, J. M., Le, M. G., Gavoille, A., Bahi, J., and Contesso, G. (1994) Angiogenesis and risk of breast cancer in women with fibrocystic disease [letter]. J. Natl. Cancer Inst. 86, 635–636.

    Article  PubMed  CAS  Google Scholar 

  51. Olivarez, D., Ulbright, T., DeRiese, W., Foster, R., Reister, T., Einhorn, L., and Sledge, G. (1994) Neovascularization in clinical stage A testicular germ cell tumor: prediction of metastatic disease. Cancer Res. 54, 2800–2802.

    PubMed  CAS  Google Scholar 

  52. Bundred, N., Bowcott, M., Walls, J., Faragher, E., and Knox, F. (1994) Angiogenesis in breast cancer predicts node metastasis and survival. Br. J. Surg. 81, 768 (Abstract).

    Article  Google Scholar 

  53. Costello, P., McCann, A., Carney, D. N., and Dervan, P. A. (1995) Prognostic significance of microvessel density in lymph node negative breast carcinoma. Hum. Pathol. 26, 1181–1184.

    Article  PubMed  CAS  Google Scholar 

  54. Paweletz, N. and Knierim, M. (1989) Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol. 9, 197–242.

    Article  PubMed  CAS  Google Scholar 

  55. Blood, C. H. and Zetter, B. R. (1990) Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta. 1032, 89–118.

    PubMed  CAS  Google Scholar 

  56. Bicknell, R. and Harris, A. L. (1991) Novel growth regulatory factors and tumor angiogenesis. Eur. J. Cancer 27, 781–785.

    Article  PubMed  CAS  Google Scholar 

  57. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res. 55, 3964–3968.

    PubMed  CAS  Google Scholar 

  58. Brown, D. M., Hong, S. P., Farrell, C. L., Pierce, G. F., and Khouri, R. K. (1995) Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc. Natl. Acad. Sci. USA 92, 5920–5924.

    Article  PubMed  CAS  Google Scholar 

  59. Moghaddam, A., Zhang, H. T., Fan, T. P., Hu, D. E., Lees, V. C., Turley, H., (1995) Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. USA 92, 998–1002.

    Article  PubMed  CAS  Google Scholar 

  60. Anandappa, S. Y., Winstanley, J. H., Leinster, S., Green, B., Rudland, P.S., andBarraclough, R. (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br. J. Cancer 69, 772–776.

    Article  PubMed  CAS  Google Scholar 

  61. Reynolds, K., Farzaneh, F., Collins, W. P., Campbell, S., Bourne, T. H., Lawton, F., (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J. Natl. Cancer Inst. 86, 1234–1238.

    Article  PubMed  CAS  Google Scholar 

  62. Garver, R. J., Radford, D. M., Donis, K. H., Wick, M. R., and Milner, P. G. (1994) Midkine and pleiotrophin expression in normal and malignant breast tissue. Cancer 74, 1584–1590.

    Article  PubMed  Google Scholar 

  63. Janot, F., el, N. A., Morrison, R. S., Liu, T. J., Taylor, D. L., and Clayman, G. L. (1995) Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologic differentiation. Int. J. Cancer 64, 117–123.

    Article  PubMed  CAS  Google Scholar 

  64. Gomm, J J, Smith, J., Ryall, G. K., Ballic, R., Turnbull, L., and Coombes, R. C. (1991) Localisation of basic fibroblast growth factor and transforming growth factor b1 in the human mammary gland. Cancer Res. 51, 4685–4692.

    PubMed  CAS  Google Scholar 

  65. Zarnegar, R. and DeFrances, M. C. (1993) Expression of HGF-SF in normal and malignant human tissues. Exs. 65, 181–199.

    PubMed  CAS  Google Scholar 

  66. Daa, T., Kodama, M., Kashima, K., Yokoyama, S., Nakayama, I., and Noguchi, S. (1993) Identification of basic fibroblast growth factor in papillary carcinoma of the thyroid. Acta Pathol. Jpn. 43, 582–589.

    PubMed  CAS  Google Scholar 

  67. Wong, S. Y., Purdie, A. T., and Han, P. (1992) Thrombospondin and other possible related matrix proteins in malignant and benign breast disease. Am. J. Pathol. 140, 1473–1482.

    PubMed  CAS  Google Scholar 

  68. Schultz-Hector, S. and Haghayegh, S. (1993) B-Fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 53, 1444–1449.

    PubMed  CAS  Google Scholar 

  69. Alvarez, J. A., Baird, A., Tatum, A., Daucher, J., Chorsky, R., Gonzalez, A. M. and Stopa, E. G. (1992) Localisation of basic fibroblast growth factor and vascular endothelial cell growth factor in human glial neoplasms. Mod. Pathol. 5, 303–307.

    PubMed  CAS  Google Scholar 

  70. Guidi, A. J., Abu, J. G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., and Brown, L. F. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J. Natl. Cancer Inst. 87, 1237–1245.

    Article  PubMed  CAS  Google Scholar 

  71. Zagzag, D., Brem, S., and Robert, F. (1988) Neovascularization and tumor growth in the rabbit brain. A model for experimental studies of angiogenesis and the blood-brain barrier. Am. J. Pathol. 131, 361–372.

    PubMed  CAS  Google Scholar 

  72. Visscher, D. W., DeMattia, F., Ottosen, S., Sarkar, F. H., and Crissman, J. D. (1995) Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma. Mod. Pathol. 8, 665–670.

    PubMed  CAS  Google Scholar 

  73. Mattern, J., Koomagi, R., and Volm, M. (1996) Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumor cell proliferation in human epidermoid lung carcinoma. Br. J. Cancer 73, 931–934.

    Article  PubMed  CAS  Google Scholar 

  74. Viglietto, G., Romano, A., Maglione, D., Rambaldi, M., Paoletti, I., Lago, C., (1996) Neovascularisation in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta growth factor. Oncogene 13, 577–587.

    PubMed  CAS  Google Scholar 

  75. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. (1994) Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res. 85, 1045–1049.

    Article  PubMed  CAS  Google Scholar 

  76. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shira, S., and Nose, T. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res. 56, 2185–2190.

    PubMed  CAS  Google Scholar 

  77. O’Brien, T., Cranston, D., Fuggle, S., Bicknell, R., and Harris, A. L. (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55, 510–513.

    PubMed  Google Scholar 

  78. Maeda, K., Chung, Y. S., Ogawa, Y., Kang, S., Takatsuka, S., Ogawa, M., Sawada, T., and Sowa, M. (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77, 858–863.

    Article  PubMed  CAS  Google Scholar 

  79. Inoue, K., Ozeki, Y., Suganuma, T., Sugiura, Y., and Tanaka, S. (1996) Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma-assocation with angiogenesis and tumor progression. Cancer 79, 206–213.

    Article  Google Scholar 

  80. Ohta, Y., Endo, Y., Tanaka, M., Shimizu, J., Oda, M., Hayashi, Y., (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin. Cancer Res. 2, 1411–1416.

    PubMed  CAS  Google Scholar 

  81. Toi, M., Hoshina, S., Taniguchi, T., Yamamoto, Y., Ishitsuka, H., and Tominaga, T. (1995) Expression of platelet derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 64, 79–82.

    Article  PubMed  CAS  Google Scholar 

  82. Takahashi, Y., Bucana, C., Liu, W., Yoneda, J., Kitadai, Y., Cleary, K. R., and Ellis, L. M. (1996) Platelet-derived endothelial cell growth factor in human colon angiogenesis: role of infiltrating cells. J. Natl. Cancer Inst. 88, 1146–1151.

    Article  PubMed  CAS  Google Scholar 

  83. Takebayashi, Y., Akiyama, S., Akiba, S., Yamada, K, Miyadera, K., Sumizawa, T., (1996) Clinicpathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 88, 1110–1117.

    Article  PubMed  CAS  Google Scholar 

  84. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., (1996) The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer 73, 275–280.

    Article  PubMed  CAS  Google Scholar 

  85. Fujimoto, K., Ichimori, Y., Kakizoe, T., Okajima, E., Sakamoto, H., Sugimura, T., and Terada, M. (1991) Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma. Biochem. Biophys. Res. Comm. 180, 386–392.

    Article  PubMed  CAS  Google Scholar 

  86. Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta 1221, 211–214.

    Article  PubMed  CAS  Google Scholar 

  87. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. (1994) Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst. 86, 356–361.

    Article  PubMed  CAS  Google Scholar 

  88. Li, V., Folkerth, R., Watanabe, H., Yu, C., Rupnick, M., Barnes, P., (1994) Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors. Lancet 344, 82–86.

    Article  PubMed  CAS  Google Scholar 

  89. Kendall, R. L. and Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl..Acad. Sci. USA 90, 10,705–10, 709.

    Google Scholar 

  90. Good, D. J., Polverini, P. J., Rastinejad, F., Le, B. M., Lemons, R. S., Frazier, W. A., and Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. USA 87, 6624–6628.

    Article  PubMed  CAS  Google Scholar 

  91. Rastinejad, F., Polverini, P. J., and Bouck, N. P. (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345–355.

    Article  PubMed  CAS  Google Scholar 

  92. Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H. J., de Tribolet, N., and Cavenee, W. K. (1994) Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8, 171–176.

    Article  PubMed  Google Scholar 

  93. O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328.

    Google Scholar 

  94. Zabrenetzky, V., Harris, C. C., Steeg, P. S., and Roberts, D. (1994) Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines. Int. J. Cancer 59, 191–195.

    Article  PubMed  CAS  Google Scholar 

  95. Weinstat-Saslow, D. L., Zabrenetzky, V. S., Van, H. K., Frazier, W. A., Roberts, D. D., and Steeg, P. S. (1994) Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54, 6504–6511.

    PubMed  CAS  Google Scholar 

  96. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582–1584.

    Article  PubMed  CAS  Google Scholar 

  97. Volpert, O., Tolsma, S., Pellerin, S., Feige, J., Chen, H., Mosher, D., and Bouck, N. (1995) Inhibition of angiogenesis by thrombospondin-2. Biochim. Biophys. Res. Comm. 217, 326–332.

    Article  CAS  Google Scholar 

  98. Vlodaysky, I., Korner, G., Ishai, M. R., Bashkin, P., Bar, S. R., and Fuks, Z. (1990) Extracellular matrix-resident growth factors and enzymes: possible involvement in tumor metastasis and angiogenesis. Cancer Metastasis Rev. 9, 203–226.

    Article  Google Scholar 

  99. Hanneken, A., Maher, P., and Baird, A. (1995) High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells-implications for the modulation of FGF-2. J. Cell Biol. 128, 1221–1228.

    Article  PubMed  CAS  Google Scholar 

  100. Friesel, R. E. and Maciag, T. (1995) Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J. 9, 919–925.

    PubMed  CAS  Google Scholar 

  101. Pepper, M. and Montesano, R. (1990) Proteolytic balance and capillary morphogenesis. Cell Diff. Dey. 32, 319–328.

    Article  CAS  Google Scholar 

  102. Fisher, C., Gilbertson, B. S., Powers, E. A., Petzold, G., Poorman, R., and Mitchell, M. A. (1994) Interstitial collagenase is required for angiogenesis in vitro. Del/. Biol. 162, 499–510.

    Article  CAS  Google Scholar 

  103. Grondahl-Hansen, J., Christensen, I. J., Rosenquist, C., Brunner, N., Mouridsen, H. T., Dano, K., and Blichert, T. M. (1993) High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis. Cancer Res. 53, 2513–2521.

    PubMed  CAS  Google Scholar 

  104. Janicke, F., Schmitt, M., Pache, L., Ulm, K., Harbeck, N., Hofler, H., and Graeff, H. (1993) Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res. Treat. 24, 195–208.

    Article  PubMed  CAS  Google Scholar 

  105. Foekens, J. A., Schmitt, M., van, P. W., Peters, H. A., Bontenbal, M., Janicke, F., and Klijn, J. G. (1992) Prognostic value of urokinase-type plasminogen activator in 671 primary breast cancer patients. Cancer Res. 52, 6101–6105.

    PubMed  CAS  Google Scholar 

  106. Duffy, M. J., Reilly, D., O’Sullivan, C., O’Higgins, N., Fennelly, J. J., and Andreasen, P. (1990) Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res. 50, 6827–6829.

    PubMed  CAS  Google Scholar 

  107. Schmitt, M., Janicke, F., Moniwa, N., Chucholowski, N., Pache, L., and Graeff, H. (1992) Tumor-associated urokinase-type plasminogen activator: biological and clinical significance. Biol. Chem. Hoppe Seyler 373, 611–622.

    Article  PubMed  CAS  Google Scholar 

  108. Spyratos, F., Martin, P. M., Hacene, K., Romain, S., Andrieu, C., Ferrero, P. M., (1992) Multiparametric prognostic evaluation of biological factors in primary breast cancer. J. Natl. Cancer Inst. 84, 1266–1272.

    Article  PubMed  CAS  Google Scholar 

  109. Sumiyoshi, K., Serizawa, K., Urano, T., Takada, Y., Takada, A., and Baba, S. (1992) Plasminogen activator system in human breast cancer. Int. J. Cancer 50, 345–348.

    Article  PubMed  CAS  Google Scholar 

  110. Ganesh, S., Sier, C. F. M., Heerding, M. M., Griffioen, G., Lamers, C. B. H. W., and Verspaget, H. W. (1994) Urokinase receptor and colorectal cancer survival. Lancet 344, 401–402.

    Article  PubMed  CAS  Google Scholar 

  111. Hildenbrand, R., Dilger, I., Horlin, A., and Stutte, H. J. (1995) Urokinase plasminogen activator induces angiogenesis and tumor vessel invasion in breast cancer. Pathol. Res. Pract. 191, 403–409.

    Article  PubMed  CAS  Google Scholar 

  112. Nguyen, M., Strubel, N. A., and Bischoff, J. (1993) A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature 365, 267–269.

    Article  PubMed  CAS  Google Scholar 

  113. Kaplanski, G., Farnarier, C., Benoliel, A., Foa, C., Kaplanski, S., and Bongrand, P. (1994) A novel role for E- and P-selectins: shape of endothelial cell monolayers. J. Cell Sci. 107, 2449–2457.

    PubMed  CAS  Google Scholar 

  114. Koch, A., Halloran, M. M., Haskell, C. J., Shah, M. R., and Polverini, P. J. (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376, 517–519.

    Article  PubMed  CAS  Google Scholar 

  115. Leavesley, D. I., Schwartz, M. A., Rosenfeld, M., and Cheresh, D. A. (1993) Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121, 163–170.

    Article  PubMed  CAS  Google Scholar 

  116. Davis, C. M., Danehower, S. C., Laurenza, A., and Molony, J. L. (1993) Identification of a role of the vitronectin receptor and protein kinase C in the induction of endothelial cell vascular formation. J. Cell Biochem. 51, 206–218.

    Article  PubMed  CAS  Google Scholar 

  117. Bauer, J., Margolis, M., Schreiner, C., Edgell, C. J., Azizkhan, J, Lazarowski, E., and Juliano, R. L. (1992) In vitro model of angiogenesis using a human endothelium-derived permanent cell line: contributions of induced gene expression, G-proteins, and integrins. J. Cell Physiol. 153, 437–449.

    Article  PubMed  CAS  Google Scholar 

  118. Luscinskas, F. W. and Lawler, J. (1994) Integrins as dynamic regulators of vascular function. FASEB J. 8, 929–938.

    PubMed  CAS  Google Scholar 

  119. Brooks, P. C., Clark, R. A., and Cheresh, D. A. (1994) Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569–571.

    Article  PubMed  CAS  Google Scholar 

  120. Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994) Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157–1164.

    Article  PubMed  CAS  Google Scholar 

  121. Brooks, P. C., Stromblad, S., Klemke, R., Visscher, D., Sarkar, F. H., and Cheresh, D. A. (1995) Antiintegrin [33av blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Invest. 96, 1815–1822.

    Article  PubMed  CAS  Google Scholar 

  122. Gamble, J. R., Matthias, L. J., Meyer, G., Kaur, P., Russ, G., Faull, R., (1993) Regulation of in vitro capillary tube formation by anti-integrin antibodies. J. Cell Biol. 121, 931–943.

    Article  PubMed  CAS  Google Scholar 

  123. Jackson, C. J., Knop, A., Giles, I., Jenkins, K, and Schrieber, L. (1994) VLA-2 mediates the interaction of collagen with endothelium during in vitro vascular tube formation. Cell Biol. Int. 18, 859–867.

    Article  PubMed  CAS  Google Scholar 

  124. Zocchi, M. R. and Poggi, A. (1993) Lymphocyte-endothelial cell adhesion molecules at the primary tumor site in human lung and renal cell carcinomas [letter]. J. Natl. Cancer Inst. 85, 246–247.

    Article  PubMed  CAS  Google Scholar 

  125. Dvorak, H. F. (1987) Thrombosis and cancer. Hum. Pathol. 18, 275–284.

    Article  PubMed  CAS  Google Scholar 

  126. Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y. M.,(1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359, 848–851.

    Article  PubMed  CAS  Google Scholar 

  127. Schadendorf, D., Heidel, J., Gawlik, C., Suter, L., and Czarnetzki (1995) Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J. Natl. Cancer Inst. 87, 366–371.

    Article  PubMed  CAS  Google Scholar 

  128. Kageshita, T., Yoshii, A., Kimura, T., Kuriya, N., Ono, T., Tsujisaki, M., (1993) Clinical relevance of ICAM-1 expression in prmary lesions and serum of patients with malignant melanoma. Cancer Res. 53, 4927–4932.

    PubMed  CAS  Google Scholar 

  129. Banks, R. E., Gearing, A. J., Hemingway, I. K., Norfolk, D. R., Perren, T. J., and Selby, P. J. (1993) Circulating intercellular adhesion molecule-1 (ICAM-1), malignancies. Br. J. Cancer 68, 122–124.

    Article  PubMed  CAS  Google Scholar 

  130. Bauer, H. C., Steiner, M., and Bauer, H. (1992) Embryonic development of the CNS microvasculature in the mouse: new insights into the structural mechanisms of early angiogenesis. Exs 61, 64–68.

    PubMed  CAS  Google Scholar 

  131. Gamble, J. R., Khew, G. Y., and Vadas, M. A. (1993) Transforming growth factor-beta inhibits E-selectin expression on human endothelial cells. J. Immunol. 150, 4494–4503.

    PubMed  CAS  Google Scholar 

  132. Warren, T., Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Feder, J., Connolly, D. T. (1989) Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309–1312.

    Article  PubMed  Google Scholar 

  133. Paku, S. and Lapis, K. (1993) Morphological aspects of angiogenesis in experimental liver metastases. Am. J. Pathol. 143, 926–936.

    PubMed  CAS  Google Scholar 

  134. Lauk, S., Zietman, A., Skates, S., Fabian, R., and Suit, H. D. (1989) Comparative morphometric study of tumor vasculature in human squamous cell carcinomas and their xenotransplants in athymic nude mice. Cancer Res. 49, 4557–4561.

    PubMed  CAS  Google Scholar 

  135. Smolle, J., Soyer, H. P., Hofmann-Wellenhof, Smolle-Juettner, F. M., and Kerl, H. (1989) Vascular architecture of melanocytic skin tumors. Path. Res. Pract. 185, 740–745.

    Article  CAS  Google Scholar 

  136. Cockerell, C. J., Sonnier, G., Kelly, L., and Patel, S. (1994) Comparative analysis of neovascularisation in primary cutaneous melanoma and Spitz nevus. Am. J. Dermatopathol. 16, 9–13.

    Article  PubMed  CAS  Google Scholar 

  137. Folberg, R., Rummelt, V., Ginderdeuren, R.-V., Hwang, T., Woolson, R., Pe’er, J., and Gruman, L. (1993) The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 100, 1389–1398.

    PubMed  CAS  Google Scholar 

  138. Jain, R. K. (1994) Barriers to drug delivery in solid tumors. Sci. Am. 271, 58–65.

    Article  PubMed  CAS  Google Scholar 

  139. Vaupel, P., Kallinowski, F., and Okunieff, P. (1990) Blood flow, oxygen consumption and tissue oxygenation of human tumors. Adv. Exp. Med. Biol. 277, 895–905.

    Article  PubMed  CAS  Google Scholar 

  140. Jain, R. K. (1990) Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev. 9, 253–266.

    Article  PubMed  CAS  Google Scholar 

  141. Mitchell, B. S., Schumacher, U., and Kaiserling, E. (1994) Are tumors innervated? Immunohistological investigations using antibodies against the neuronal marker protein gene product 9.5 (PGP 9.5) in benign, malignant and experimental tumors. Tumor Biol. 15, 269–274.

    Article  CAS  Google Scholar 

  142. Nystrom, C., Forssman, L., and Roos, B. (1969) Myometrial blood flow studies in carcinoma of the corpus uteri. Acta Radiol. Ther. 8, 193–198.

    Article  CAS  Google Scholar 

  143. Kurjak, A., Salihagic, A., Kupesic, U. S., and Predanic, A. (1992) Clinical value of the assessment of gynaecological tumour angiogenesis by transvaginal colour Doppler. Ann. Med. 24, 97–103.

    Article  PubMed  CAS  Google Scholar 

  144. Frouge, C., Guinbretiere, J., Contesso, G., di Paola, R., and Blery, M. (1994) Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest. Radiol. 29, 1043–1049.

    Article  PubMed  CAS  Google Scholar 

  145. Lee, W. J., Chu, J. S., Houng, S. J., Chung, M. F., Wang, S. M., and Chen, K. M. (1995) Breast cancer angiogenesis: a quantitative morphologic and Doppler imaging study. Ann. Surg. Oncol. 2, 246–251.

    Article  PubMed  CAS  Google Scholar 

  146. Antonic, J. and Rakar, S. (1995) Colour and pulsed doppler US and tumor marker CAl25 in differentiation between benign and malignant ovarian masses. Anticancer Res. 15, 1527–1532.

    PubMed  CAS  Google Scholar 

  147. Wu, C. C., Lee, C. N., Chen, T. M., Shyu, M. K., Hsieh, C. Y., Chen, H. Y., and Hsieh, F. J. (1994) Incremental angiogenesis assessed by color Doppler ultrasound in the tumorigenesis of ovarian neoplasms. Cancer 73, 1251–1256.

    Article  PubMed  CAS  Google Scholar 

  148. Carter, J., Lau, M., Saltzman, A, Hartenbach, E., Chen, M., Johnson, P., (1994) Gray scale and color flow Doppler characterization of uterine tumors. J. Ultrasound Med. 13, 835–840.

    PubMed  CAS  Google Scholar 

  149. Ernst, H., Hahn, E., Balzer, T., Schlief, R., and Heyder, N. (1996) Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J. Clin. Ultrasound. 24, 31–35.

    Article  PubMed  CAS  Google Scholar 

  150. Huang, S.C., Yu, C. H., Huang, R. T., Hsu, K. F., Tsai, Y. C., and Chou, C. Y. (1996) Intratumoral blood flow in uterine myoma correlated with a lower tumor size and volume, but not correlated with cell proliferation or angiogenesis. Obstet. Gynecol. 87, 1019–1024.

    Article  PubMed  CAS  Google Scholar 

  151. Gilles, R., Zafrani, B., Guinebretiere, J. M., Meunier, M., Lucidarme, O., Tardivon, A. A., (1995) Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196, 415–419.

    PubMed  CAS  Google Scholar 

  152. Guidi, A., Fischer, L., Harris, J., and Schnitt, S. (1994) Microvessel density and distribution in ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 86, 614–619.

    Article  PubMed  CAS  Google Scholar 

  153. Engels, K., Fox, S. B., Gatter, K. C., and Hams, A. L. (1995) Distinct angiogenenic patterns are associated with high grade in-situ ductal carcinoma of breast. J. Pathol. 181, 207–212.

    Article  Google Scholar 

  154. Sterns, E., Zee, B., SenGupta, S., and Saunders, F. (1996) Thermography: its relation to pathologic characteristics, vascularity, proliferation rate and survival of patinets with invasive ductal carcinoma of the breast. Cancer 77, 1324–1328.

    Article  PubMed  CAS  Google Scholar 

  155. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. (1996) Association between tumor hypoxia and malignant progression in advance cancer of the uterine cervic. Cancer Res. 56, 4509–4515.

    PubMed  CAS  Google Scholar 

  156. Brizel, D., Scully, S., Harrelson, J., Layfield, L., Beach, J., Prosnitz, L., and Dewhitst, M. (1996) Tumor oxygenation profiles for the likelihood of distant metastases in human soft tissue sarcomas. Cancer Res. 56, 941–943.

    PubMed  CAS  Google Scholar 

  157. Shweiki, D., Neeman, M., Itin, A., and Keshet, E. (1995) Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc. Natl. Acad. Sci. USA 92, 768–772.

    Article  PubMed  CAS  Google Scholar 

  158. Brem, S. S., M., J. H. and Gullino, P. M. (1978) Angiogenesis as a marker of pre-neoplastic lesions of the human breast. Cancer 41, 239–248.

    Article  PubMed  CAS  Google Scholar 

  159. Jensen, H. M., Chen, I., DeVault, M. R., and Lewis, A. E. (1982) Angiogenesis induced by “normal” human breast tissue: a probable marker for precancer. Science 218, 293–295.

    Article  PubMed  CAS  Google Scholar 

  160. Chodak, G. W., Haudenschild, C., Gittes, R. F., and Folkman, J. (1980) Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder. Ann. Surg. 192, 762–771.

    Article  PubMed  CAS  Google Scholar 

  161. Fregene, T. A., Kellog, C., and Pienta, K. J. (1994) Microvessel quantitation as a measure of angiogenic activity in benign breast tissues lesions: a marker for precancerous disease ? Int. J. Oncol. 4, 1199–1202.

    PubMed  CAS  Google Scholar 

  162. Heffelfinger, S., Yassin, R., Miller, M., and Lower, E. (1996) Vascularity of proliferative breast disease and carcinoma in situ correlates with histological features. Clin. Cancer Res. 2, 1873–1878.

    PubMed  CAS  Google Scholar 

  163. Montironi, R., Galluzzi, C., Diamanti, L., Taborro, R., Scarpelli, M., and Pisani, E. (1993) Prostatic intra-epithelial neoplasia. Qualitative and qualitative analysis of the blood capillary architecture. Path. Res Pract. 189, 542–548.

    Article  PubMed  CAS  Google Scholar 

  164. Deering, R. E., Bigler, S. A., Brown, M., and Brawer, M. K. (1995) Microvascularity in benign prostatic hyperplasia. Prostate 26, 111–115.

    Article  PubMed  CAS  Google Scholar 

  165. Fox, S. B., Leek, R. D., Smith, K., Hollyer, J., Greenall, M., and Harris, A. L. (1994) Tumor angiogenesis in node-negative breast carcinomas: relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res. Treat. 29, 109–116.

    Article  PubMed  CAS  Google Scholar 

  166. Toi, M., Inada, K., Suzuki, H., and Tominaga, T (1995) Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res. Treat. 36, 193–204.

    Article  PubMed  CAS  Google Scholar 

  167. Ogawa, Y., Chung, Y., Nakata, B., Takatsuka, S., Maeda, K., Sawada, T., (1995) Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br. J. Cancer 71, 1297–1301.

    Article  PubMed  CAS  Google Scholar 

  168. Gasparini, G. and Harris, A. L. (1994) Does improved control of tumor growth require an anti-cancer therapy targeting both neoplastic and intratumoral endothelial cells? Eur. J. Cancer 30A, 201–206.

    Article  Google Scholar 

  169. Lipponen, P., Ji, H., Aaltomaa, S., and Syrjanen, K. (1994) Tumor vascularity and basement membrane structure in breast cancer as related to tumor histology and prognosis. J. Cancer Res. Clin. Oncol. 120, 645–650.

    Article  PubMed  CAS  Google Scholar 

  170. Smith-McCune, K. and Weidner, N. (1994) Demonstration and characterization of the angiogenic properties of cervival dysplasia. Cancer Res. 54, 800–804.

    PubMed  CAS  Google Scholar 

  171. Wiggins, D. L., Granai, C. O., Steinhoff, M. M., and Calabresi, P. (1995) Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol. Oncol. 56, 353–356.

    Article  PubMed  CAS  Google Scholar 

  172. Palczak, R. and Splawinski, J. (1989) Angiogenic activity and neovascularization in adenocarcinoma of endometrium. Int. J. Gynaecol. Obstet. 29, 343–357.

    Article  PubMed  CAS  Google Scholar 

  173. Hollingsworth, H. C., Kohn, E. C., Steinberg, S. M., Rothenberg, M. L., and Merino, M. J. (1995) Tumor angiogenesis in advanced stage ovarian carcinoma [see comments]. Am. J. Pathol. 147, 33–41.

    PubMed  CAS  Google Scholar 

  174. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. (1993) Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401–409.

    PubMed  CAS  Google Scholar 

  175. Hall, M. C., Troncoso, P., Pollack, A., Zhau, H. Y., Zagars, G. K., Chung, L. W., and von, E. A. (1994) Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology 44, 869–875.

    Article  PubMed  CAS  Google Scholar 

  176. Jaeger, T., Weidner, N., Chew, K., Moore, D., Kerschman, R., Waldman, F., and Carrol, P. (1995) Tumor angiogenesis correlates with lymph node metastasis in invasive bladder cancer. J. Urol. 154, 69–71.

    Article  PubMed  CAS  Google Scholar 

  177. Macchiarelli, G., Nottola, S. A., Vizza, E., Kikuta, A., Murakami, T., and Motta, P. M. (1991) Ovarian microvasculature in normal and hCG stimulated rabbits. A study of vascular corrosion casts with particular regard to the interstitium. J. Submicrosc. Cytol. Pathol. 23, 391–395.

    PubMed  CAS  Google Scholar 

  178. Giatromanolaki, A., Koukourakis, O’Byrne, K., Fox, S., Whitehouse, R., Talbot, D., (1995) Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol. 179, 80–88.

    Article  Google Scholar 

  179. Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Sawada, T., Yamashita, Y., et, al. (1995) Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol. 13, 477–481.

    PubMed  CAS  Google Scholar 

  180. Saclarides, T. J., Speziale, N. J., Drab, E., Szeluga, D. J., and Rubin, D. B. (1994) Tumor angiogenesis and rectal carcinoma. Dis. Colon. ‘Rectum. 37, 921–926.

    Article  PubMed  CAS  Google Scholar 

  181. Klijanienko, J., El-Naggar, A., de Braud, F., Rodriguez-Peralto, J., Rodriguez, R., Itzhaki, M., (1995) Tumor vascularisation, mitotic index, histopathological grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 75, 1649–1656.

    Article  PubMed  CAS  Google Scholar 

  182. Leedy, D. A., Trune, D. R., Kronz, J. D., Weidner, N., and Cohen, J. I. (1994) Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol. Head Neck Surg. 111, 417–422.

    PubMed  CAS  Google Scholar 

  183. Gasparini, G., Weidner, N., Maluta, S., Pozza, F., Boracchi, P., Mezzetti, M., (1993) Intratumoral microvessel density and p53 protein: correlation with metastasis in head-and-neck squamous-cell carcinoma. Int. J. Cancer 55, 739–744.

    Article  PubMed  CAS  Google Scholar 

  184. Zatterstrom, U., Brun, E., Willen, R., Kjellen, E., and Wennerberg, J. (1995) Tumor angiogenesis and prognosis in squamous carcinoma of the head and neck. Head Neck 17, 312–318.

    Article  PubMed  CAS  Google Scholar 

  185. Albo, D., Granick, M., Jhala, N., Atkinson, B., and Solomon, M. (1994) The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck. Ann. Plast. Surg. 32, 558–594.

    Article  Google Scholar 

  186. Ohsawa, M., Tomita, Y., Kuratsu, S., Kanno, H., and Aozasa, K. (1995) Angiogenesis in malignant fibrous histiocytoma. Oncology 52, 51–54.

    Article  PubMed  CAS  Google Scholar 

  187. Weidner, N. (1995) Intratumoral microvessel density as a prognostic factor in cancer. Am. J. Pathol. 147, 9–19.

    PubMed  CAS  Google Scholar 

  188. Dearnaley, D., Sloane, J., Ormerod, M., Steele, K., Coombes, R., Clink, H., (1981) Increased setection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigen. Br. J. Cancer 44, 85–90.

    Article  PubMed  CAS  Google Scholar 

  189. Osborne, M. P., Wong, G. Y., Asina, S., Old, L. J., Cote, R. J., and Rosen, P. P. (1991) Sensitivity of immunocytochemical detection of breast cancer cells in human bone marrow. Cancer Res. 51, 2706–2709.

    PubMed  CAS  Google Scholar 

  190. Pantel, K., Schlimok, G., Angstwurn, M., Weckermann, D., Schmaus, W., Gath, H., (1994) Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 3, 165–173.

    Article  PubMed  CAS  Google Scholar 

  191. Gasparini, G., Fox, S., Verderio, P., E., B., Bevilacqua, P., Borrachi, P., Dante, S., (1996) The determination of angiogenesis adds information to estrogen receptor status in predicting the efficacy of adjuvant tamoxifen in node positive breast cancer patients. Clin. Cancer Res. 2, 1191–1198.

    PubMed  CAS  Google Scholar 

  192. Gasparini, G. and Harris, A. L. (1995) Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J. Clin. Oncol. 13, 765–782.

    PubMed  CAS  Google Scholar 

  193. Fox, S., Engels, K., Comley, M., Whitehouse, R., Turley, H., Gatter, K., and Harris, A. (1997) Relationship of elevated tumor thymidine phosphorylase in node positive breast carcinomas to the effects of adjuvant CMF. Ann. Oncol. 8, 271–275.

    Article  PubMed  CAS  Google Scholar 

  194. Larsen, N. S. (1993) Angiogenesis research yields new approaches to cancer treatment and prognosis [news]. J. Natl. Cancer Inst. 85, 1629–1630.

    Article  PubMed  CAS  Google Scholar 

  195. Dixon, J., Kaklamanis, L., Turley, H., Hickson, I. D., Leek, R. D., Harris, A. L., and Gatter, K. C. (1994) Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J. Clin. Pathol. 47, 43–47.

    Article  PubMed  CAS  Google Scholar 

  196. Fina, L., Molgaard, H. V., Robertson, D., Bradley, N. J., Monaghan, P., Delia, D., (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75, 2417–2426.

    PubMed  CAS  Google Scholar 

  197. Silverstein, R. L., Baird, M., Lo, S. K., and Yesner, L. M. (1992) Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells. Role of CD36 as a thrombospondin receptor. J. Biol. Chem. 267, 16,607–16, 612.

    Google Scholar 

  198. Wellicome, S. M., Thornhill, M. H., Pitzalis, C., Thomas, D. S., Lauchbury, J. S., Panayi, G. S., and Haskard, D. O. (1990) A monoclonal antibody that detects a novel antigen on endothelial cells that is induced by tumor necrosis factor, IL-1, or lipopolysaccharide. J. Immunol. 144, 2558–2565.

    PubMed  CAS  Google Scholar 

  199. Metzelaar, M. J., Schuurman, H. J., Heijnen, H. F., Sixma, J. J., and Nieuwenhius, H. K. (1991) Biochemical and immunohistochemical characteristics of CD62 and CD63 monoclonal antibodies. Expression of GMP-140 and LIMP-CD63 (CD63 antigen) in human lymphoid tissues. Virchows Arch. B Cell. Pathol. 61, 269–277.

    CAS  Google Scholar 

  200. de Fougerolles, A., Stacker, S. A., Schwarting, R., and Springer, T. A. (1991) Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med. 174, 253–267.

    Article  PubMed  Google Scholar 

  201. Kuzu, I., Bicknell, R., Fletcher, C. D., and Gatter, K. C. (1993) Expression of adhesion molecules on the endothelium of normal tissue vessels and vascular tumors. Lab. Invest. 69, 322–328.

    PubMed  CAS  Google Scholar 

  202. Rettig, W. J., Garin, C. P., Healey, J. H., Su, S. L., Jaffe, E. A., and Old, L. J. (1002) Indentification of endosialin, a cell surface gylcoprotein of vascular endothelial cells in human cancer. Proc. Natl. Acad. Sci. USA 89, 10,832–10, 836.

    Google Scholar 

  203. Hagemeier, H. H., Vollmer, E., Goerdt, S., Schulze, O. K., and Sorg, C. (1986) A monoclonal antibody reacting with endothelial cells og budding vessels in tumors and inflammatory tissues, and non-reactive with normal adult tissues. Int. J. Cancer 38, 481–488.

    Article  PubMed  CAS  Google Scholar 

  204. Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O., and Ruiter, D. J. (1985) Monoclonal antibody PAL-E specific for endothelium. Lab. Invest. 52, 71–76.

    PubMed  CAS  Google Scholar 

  205. Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152, 4149–4156.

    PubMed  CAS  Google Scholar 

  206. Fregene, T. A., Khanuja, P. S., Gimotty, P. A., Kellogg, C., George, J., and Pienta, K. J. (1994) The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer. Int. J. Oncol. 5, 1437–1445.

    PubMed  CAS  Google Scholar 

  207. Bevilacqua, P., Barbareschi, M., Verderio., P., Boracchi, P., Caffo, O., Dalla Palma, P., (1994) Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma-results of a multiparametric study. Breast Cancer Res. Treat. 36, 205–217.

    Article  Google Scholar 

  208. Ogawa, Y., Chung, Y., Nakata, B., Takatsuka, S., Maeda, K., (1994) An evaluation of angiogenesis in breast cancer with factor VIII related antigen staining. Proc. Am. Assoc. Cancer Res. 35, 186 (Abstract 1113).

    Google Scholar 

  209. Obermair, A., Kurz, C., Czerwenka, K., Thoma, M., Kaider, A., and Wagner, T. (1995) Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int. J. Cancer 62, 126–131.

    Article  PubMed  CAS  Google Scholar 

  210. Kohlberger, P., Obermair Sliutz, G., Heinzl, H., Koelbl, H., Breitenecker, G., Gitsch, G., and Kainz, C. (1996) Quantitive immunohistochemistry of factor VIII-related antigen in breast carcinoma. Am. J. Clin. Pathol. 105, 705–710.

    PubMed  CAS  Google Scholar 

  211. Simpson, J., Ahn, C., Battifora, H., and Esteban, J. (1996) Endothelial area as a prognostic indicator for invasive breast carcinoma. Cancer 77, 2077–2085.

    Article  PubMed  CAS  Google Scholar 

  212. Heinman, R., Ferguson, D., Powers, C., Recant, W., Weichselbaum, R., and Hellman, S. (1996) Angiogenesis as a predictor of long term survival for patients wit node-negative breast cancer. J. Natl. Cancer Inst. 88, 1764–1769.

    Article  Google Scholar 

  213. Goulding, H., Abdul, R. N., Robertson, J. F., Bell, J. A., Elston, C. W., Blarney, R. W., and Ellis, I. O. (1995) Assessment of angiogenesis in breast carcinoma: an important factor in prognosis? Hum. Pathol. 26, 1196–1200.

    Article  PubMed  CAS  Google Scholar 

  214. Morphopoulos, G., Pearson, M., Ryder, W., Howell, A., and Harris, M. (1996) Tumor angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J. Pathol. 180, 44–49.

    Article  PubMed  CAS  Google Scholar 

  215. Bochner, B., Cote, R., Groshen, S., Esrig, D., Freeman, J., Weidner, N., (1995) Tumor angiogenesis is an independent prognostic indicator in invasive transitional cell carcinoma of the bladder. J. Urol. 153, 456A (Abstract 909).

    Google Scholar 

  216. Philip, E., Stephenson, T., and Reed, M. (1996) Prognostic significance of angiogenesis in transitional carcinoma of the human urinary bladder. Br. J. Urol. 77, 352–357.

    Article  Google Scholar 

  217. MacLennan, G. and Bostwick, D. (1995) Microvessel density in renal cell carcinoma: lack of prognostic significance. Urology 46, 27–30.

    Article  PubMed  CAS  Google Scholar 

  218. Frank, R. E., Saclarides, T. J., Leurgans, S., Speziale, N.J., Drab, E. A., and Rubin, D. B. (1995) Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer [see comments]. Ann. Surg. 222, 695–699.

    Article  PubMed  CAS  Google Scholar 

  219. Bossi, P., Viale, G., Lee, A. K., Alfano, R., Coggi, G., and Bosari, S. (1995) Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 55, 5049–5053.

    PubMed  CAS  Google Scholar 

  220. Takebayashi, Y., Akiyama, S., Yamada, K., Akiba, S., and Aikou, T. (1996) Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78, 226–231.

    Article  PubMed  CAS  Google Scholar 

  221. Lindmark, G., Gerdin, B., Sundberg, C., Pahlman, L., Bergstrom, R., and Glimelius, B. (1996) Prognostic significance of the microvessel count in colorectal cancer. J. Clin. Oncol. 14, 461–466.

    PubMed  CAS  Google Scholar 

  222. Engel, C., Bennett, S., Chambers, A., Doig, G., Shimomatsuya, T., Horiuchi, T., (1996) Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am. J. Clin. Pathol. 20, 1260–1265.

    CAS  Google Scholar 

  223. Tanigawa, N., Amaya, H., Matsumura, M., Shimomatsuya, T., Horiuchi, T., Muraoka, R., and Iki, M. (1996) Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma. Cancer Res. 56, 2671–2676.

    PubMed  CAS  Google Scholar 

  224. Rutgers, J. L., Mattox, T. F., and Vargas, M. P. (1995) Angiogenesis in uterine cervical squamous cell carcinoma. Int. J. Gynecol. Pathol. 14, 114–118.

    Article  PubMed  CAS  Google Scholar 

  225. Kainz, C., Speiser, P., Wanner, C., Obermair, A., Tempfer, C., Sliutz, G., (1995) Prognostic value of tumour microvessel density in cancer of the uterine cervix stage IB and IIB. Anticancer Res. 15, 1549–1552.

    PubMed  CAS  Google Scholar 

  226. Kirschner, C., Alanis-Amerzcua, J., Martin, V., Luna, N., Morgan, E., Yang, J., and Yordan, E. (1996) Angiogenesis factor in endometrial carcinoma: a new prognastic indicator? Am. J. Obstet. Gynecol. 174, 1879–1884.

    Article  PubMed  CAS  Google Scholar 

  227. Van Diest, P., Zevering, L., and Baak, J. (1995) Lack of prognostic value of microvessel density counts in FIGO 3 and 4 cisplatinum treated ovarian cancer patients. Pathol. Res. Pract. 191, 25–30.

    Article  PubMed  Google Scholar 

  228. Gasparini, G., Bonoldi, E., Viale, G., Verderio, P., Boracchi, P., Panizzoni, G., (1996) Prognostic and predictive value of tumor angiogenesis in ovarian carcinomas. Int. J. Cancer 69, 205–211.

    Article  PubMed  CAS  Google Scholar 

  229. Yamazaki, K., Abe, S., Takekawa, H., Sukoh, N., Watanabe, N., Ogura, S., (1994) Tumor angiogenesis in human lung adenocarcinoma. Cancer 74, 2245–2250.

    Article  PubMed  CAS  Google Scholar 

  230. Macchiarini, P., Fontanini, G., Dulmet, E., de Montepreville, V., Chapelier, A., Cerrina, J., (1994) Angiogenesis: an indicator of metastasis in non-small cell lung cancer invading the thoracic inlet. Ann. Thor. Surg. 57, 1534–1539.

    Article  CAS  Google Scholar 

  231. Mattem, J., Koomagi, R., Volm, M. (1995) Vascular endothelial growth factor expression and angiogenesis in non-small cell lung carcinomas. Int. J. Oncol. 6, 1059–1062.

    Google Scholar 

  232. Fontanini, G., Bigini, D., Vignati, S., Basolo, F., Mussi, A., Lucchi, M., (1995) Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol. 177, 57–63.

    Article  PubMed  CAS  Google Scholar 

  233. Angeletti, C., Lucchi, M., Fontanini, G., Mussi, A., Chella, A., Ribechini, A., (1996) Prognostic significance of tumoral angiogenesis in completely resected late stage lung carcinoma (stage IIIA-N2). Cancer 78, 409–415.

    Article  PubMed  CAS  Google Scholar 

  234. Harpole, D. J., Richards, W. G., Herndon, J. N., and Sugarbaker, D. J. (1996) Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer. Ann. Thorac. Surg. 61, 1470–1476.

    Article  PubMed  Google Scholar 

  235. Carrau, R., Barnes, E., Snyderman, C., Petruzzelli, G., Kachman, K., Rueger, R., (1995) Tumor angiogenesis as a predictor of tumor aggressiveness and metastatic potential in squamous carcinomas of the head and neck. Inv. Metastasis 15, 197–202.

    CAS  Google Scholar 

  236. Dray, T., Hardin, N., Sofferman, R. (1995) Angiogenesis as a prognostic marker in early head and neck cancer. Ann. Otol. Rhinol. Laryngol. 104, 724–729.

    PubMed  CAS  Google Scholar 

  237. Roychowdhury, D., Tseng, A., Fu, K., Weinberg, V., and Weidner, N. (1996) New prognostic factors in nasopharyngeal carcinoma: tumor angiogenesis and c-erbB-2 expression. Cancer 77, 1419–1226.

    Article  PubMed  CAS  Google Scholar 

  238. Shpitzer, T., Chaimoff, M., Gal, R., Stern, Y., Feinmesser, R., and Segal, K. (1996) Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch. Otolaryngol. Head Neck Surg. 122, 865–868.

    Article  PubMed  CAS  Google Scholar 

  239. Graham, C., Rivers, J., Kerbel, R., Stankiewicz, K., and White, W. (1994) Extent of vascularization as a prognostic indicator in thin (0.76 mm) malignant melanomas. Am. J. Pathol. 145, 510–514.

    PubMed  CAS  Google Scholar 

  240. Busam, K., Berwick, M., Blessing, K., Fandrey, K., Kang, S., Karaoli, T.,(1995) Tumor vascularity is not a prognostic factor for malignant melanoma. Am. J. Pathol. 147, 1049–1956.

    PubMed  CAS  Google Scholar 

  241. Leon, S., Folkerth, R., and Black, P. (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77, 362–372.

    Article  PubMed  CAS  Google Scholar 

  242. Wesseling, P., Ruiter, D. J., Burger, P. C., (1994) Quantitative immunohistolgical analysis of the microvasculature in untreated human glioblastoma mutliforme. Computer-assisted image analysis of whole-tumor sections. J. Neurosurg. 81, 902–909.

    Article  PubMed  CAS  Google Scholar 

  243. Ito, T., Kitamura, H., Nakamura, N., Kameda, Y., and Kanisawa, M. (1993) A comparative study of vascular proliferation in brain metastasis of lung carcinomas. Virchows Arch. A Pathol. Anat. Histopathol. 423, 13–17.

    Article  PubMed  CAS  Google Scholar 

  244. Foss, A., Alexander, R., Jefferies, L., Hungerford, J., Harris, A., and Lightman, S. (1996) Microvessel count predicts survival in uveal melanoma. Cancer Res. 56, 2900–2903.

    PubMed  CAS  Google Scholar 

  245. Pluda, J. and Parkinson, D. (1996) Clinical implications of tumor-assiciated neovascularization and current anti-angiogenic strategies for the treatment of malignancies of pancreas. Cancer 78, 680–687.

    PubMed  CAS  Google Scholar 

  246. Hellstrom, A., Frankendal, B., Nilsson, B., Pettersson, F., Silfversward, C., and Auer, C. (1996) Primary fallopian tube carcinoma-the prognostic impact of stage, histopathology, and biological parameters. Int. J. Gynecol Cancer 6, 456–462.

    Article  Google Scholar 

  247. Liu, Q., Djuricin, G., Staren, E., Gattuso, P., Gould, V., and Shen, J. (1996) Tumor angiogenesis in phaeochromocytomas and paragangliomas. Surgery 120, 938–942.

    Article  PubMed  CAS  Google Scholar 

  248. Sulh, M., Greco, M., Jiang, T., Goswani, S., Present, D., and Steiner, G. (1996) Proliferation index and vascular density of giant cell tumors of bone. Cancer 77, 2044–2051.

    Article  PubMed  CAS  Google Scholar 

  249. Meitar, D., Crawford, S., Rademaker, A., and Cohn, S. (1996) Tumor angiogenesis correlates with metastatic disease, n-myc amplification and poor outcome in human neuroblastoma. J. Clin. Oncol. 14, 405–414.

    PubMed  CAS  Google Scholar 

  250. Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., and Dammacco, F. (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br. J. Haematol. 87, 503–508.

    Article  PubMed  CAS  Google Scholar 

  251. Segal, K., Shpitzer, T., Feinmesser, M., Stern, Y., and Feinmesser, R. (1996) Angiogenesis in follicular tumors of the thyroid. J. Surg. Oncol. 63, 95–98.

    Article  PubMed  CAS  Google Scholar 

  252. Fontanini, G., Vignati, S., Pollina, L., and Basolo, F. (1996) Microvessel count: an indicator of poor outcome in medullary thryroid carcinoma, but not in other types of thyroid carcinoma. Mod. Pathol. 9, 636–841.

    PubMed  CAS  Google Scholar 

  253. Staibano, S., Boscaino, A., Salvatore, G., Orabona, P., Palombini, L., and De Rosa, G. (1996) The prognostic significance of tumor angiogenesis in nonaggessive and aggressive basal cell carcinoma of the human skin. Human Pathol. 27, 695–700.

    Article  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fox, S.B., Harris, A.L. (2002). Diagnostic and Prognostic Significance of Tumor Angiogenesis. In: Fan, TP.D., Kohn, E.C. (eds) The New Angiotherapy. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-126-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-126-8_10

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9657-4

  • Online ISBN: 978-1-59259-126-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics